Taddio M, Doshi S, Masri M, Jeanjean P, Hikmat F, Gerlach A
Eur J Nucl Med Mol Imaging. 2024; 51(13):4026-4037.
PMID: 39008063
PMC: 11527918.
DOI: 10.1007/s00259-024-06809-4.
Purbey P, Seo J, Paul M, Iwamoto K, Daly A, Feng A
Cell Rep. 2024; 43(6):114289.
PMID: 38833371
PMC: 11315447.
DOI: 10.1016/j.celrep.2024.114289.
Lee M, Ratanachan D, Wang Z, Hack J, Adbulrahman L, Shamlin N
J Immunol. 2023; 211(4):693-705.
PMID: 37395687
PMC: 10435044.
DOI: 10.4049/jimmunol.2100793.
Nesseler J, Lee M, Nguyen C, Kalbasi A, Sayre J, Romero T
Cancers (Basel). 2020; 12(3).
PMID: 32197352
PMC: 7140082.
DOI: 10.3390/cancers12030714.
Epel B, Maggio M, Barth E, Miller R, Pelizzari C, Krzykawska-Serda M
Int J Radiat Oncol Biol Phys. 2018; 103(4):977-984.
PMID: 30414912
PMC: 6478443.
DOI: 10.1016/j.ijrobp.2018.10.041.
In Vivo Extracellular pH Mapping of Tumors Using Electron Paramagnetic Resonance.
Komarov D, Ichikawa Y, Yamamoto K, Stewart N, Matsumoto S, Yasui H
Anal Chem. 2018; 90(23):13938-13945.
PMID: 30372035
PMC: 6467789.
DOI: 10.1021/acs.analchem.8b03328.
Feasibility of in vivo three-dimensional T mapping using dicarboxy-PROXYL and CW-EPR-based single-point imaging.
Kubota H, Komarov D, Yasui H, Matsumoto S, Inanami O, Kirilyuk I
MAGMA. 2017; 30(3):291-298.
PMID: 28063096
PMC: 5518941.
DOI: 10.1007/s10334-016-0606-8.
13C-MR Spectroscopic Imaging with Hyperpolarized [1-13C]pyruvate Detects Early Response to Radiotherapy in SCC Tumors and HT-29 Tumors.
Saito K, Matsumoto S, Takakusagi Y, Matsuo M, Morris H, Lizak M
Clin Cancer Res. 2015; 21(22):5073-81.
PMID: 25673698
PMC: 8363083.
DOI: 10.1158/1078-0432.CCR-14-1717.
Pyruvate induces transient tumor hypoxia by enhancing mitochondrial oxygen consumption and potentiates the anti-tumor effect of a hypoxia-activated prodrug TH-302.
Takakusagi Y, Matsumoto S, Saito K, Matsuo M, Kishimoto S, Wojtkowiak J
PLoS One. 2014; 9(9):e107995.
PMID: 25254649
PMC: 4177858.
DOI: 10.1371/journal.pone.0107995.
Longitudinal imaging studies of tumor microenvironment in mice treated with the mTOR inhibitor rapamycin.
Saito K, Matsumoto S, Yasui H, Devasahayam N, Subramanian S, Munasinghe J
PLoS One. 2012; 7(11):e49456.
PMID: 23185335
PMC: 3502528.
DOI: 10.1371/journal.pone.0049456.
Hypoxia and drug resistance.
Teicher B
Cancer Metastasis Rev. 1994; 13(2):139-68.
PMID: 7923547
DOI: 10.1007/BF00689633.
Phase-specific cytotoxicity in vivo of hydroxyurea on murine fibrosarcoma pulmonary nodules.
Grdina D
Br J Cancer. 1982; 45(3):438-46.
PMID: 7073937
PMC: 2010915.
DOI: 10.1038/bjc.1982.72.
Cytotoxic effects of vincristine on tumour subpopulations separated from pulmonary nodules.
Grdina D, White R, Stragand J
Br J Cancer. 1983; 48(2):279-87.
PMID: 6882666
PMC: 2011441.
DOI: 10.1038/bjc.1983.183.
Enhancement of the DNA cross-linking activity of melphalan by misonidazole in vivo.
Murray D, Meyn R
Br J Cancer. 1983; 47(2):195-203.
PMID: 6824567
PMC: 2011274.
DOI: 10.1038/bjc.1983.27.
Treatment of artificially-induced pulmonary metastases with fractionated doses of vincristine and/or radiation therapy.
Grdina D, White R
Clin Exp Metastasis. 1983; 1(1):71-81.
PMID: 6543686
DOI: 10.1007/BF00118474.
Effect of misonidazole pretreatment on nitrogen mustard-induced DNA cross-linking in mouse tissues in vivo.
Murray D, Meyn R
Br J Cancer. 1984; 50(6):801-8.
PMID: 6498077
PMC: 1977012.
DOI: 10.1038/bjc.1984.259.
Cytotoxic effect in vivo of selected chemotherapeutic agents on synchronized murine fibrosarcoma cells.
Grdina D, Sigdestad C, Peters L
Br J Cancer. 1980; 42(5):677-83.
PMID: 6161629
PMC: 2010549.
DOI: 10.1038/bjc.1980.301.
Metastatic properties of murine sarcomas and carcinomas. I. Positive correlation with lung colonization and lack of correlation with s.c. tumor take.
Volpe J, Hunter N, Basic I, Milas L
Clin Exp Metastasis. 1985; 3(4):281-94.
PMID: 4075613
DOI: 10.1007/BF01585082.
Increase in radiosensitivity of lung micrometastases by hyperbaric oxygen.
Milas L, Hunter N, Ito H, Brock W, Peters L
Clin Exp Metastasis. 1985; 3(1):21-7.
PMID: 4042454
DOI: 10.1007/BF01758951.
DNA cross-linking following exposure to cis-platinum in primary and serially passaged cultured cells derived from two murine fibrosarcomas.
Murray D, Basic I, Milas L, Meyn R
Cancer Chemother Pharmacol. 1987; 20(2):133-6.
PMID: 3664932
DOI: 10.1007/BF00253967.
